Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3711623015 | Proguanil-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3711624014 | Product containing proguanil in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Proguanil-containing product in oral dose form | Is a | Product containing proguanil (medicinal product) | true | Inferred relationship | Some | ||
| Proguanil-containing product in oral dose form | Is a | Product manufactured as oral dose form (product) | true | Inferred relationship | Some | ||
| Proguanil-containing product in oral dose form | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Proguanil | true | Inferred relationship | Some | 1 | |
| Proguanil-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Proguanil-containing product in oral dose form | Plays role | Antimalarial therapeutic role | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Proguanil hydrochloride 100 mg oral tablet | Is a | False | Proguanil-containing product in oral dose form | Inferred relationship | Some | |
| atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet | Is a | False | Proguanil-containing product in oral dose form | Inferred relationship | Some | |
| proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke | Is a | False | Proguanil-containing product in oral dose form | Inferred relationship | Some | |
| atovaquon 62,5 mg + proguanilhydrochlorid 25 mg tablet | Is a | False | Proguanil-containing product in oral dose form | Inferred relationship | Some | |
| Atovaquone- and proguanil-containing product in oral dose form | Is a | True | Proguanil-containing product in oral dose form | Inferred relationship | Some | |
| Proguanil only product in oral dose form | Is a | True | Proguanil-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR